S L Silverman
Overview
Explore the profile of S L Silverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Adami G, Saag K, Mudano A, Rahn E, Wright N, Outman R, et al.
Osteoporos Int
. 2020 Feb;
31(7):1283-1290.
PMID: 32020264
Introduction: Understanding factors associated with reaching the contemplative stage of readiness to initiate osteoporosis treatment may inform the design of behavioral interventions to improve osteoporosis treatment uptake in women at...
3.
Silverman S, Kupperman E, Bukata S
Osteoporos Int
. 2016 Apr;
27(7):2197-2206.
PMID: 27112766
Unlabelled: We used the RAND UCLA appropriateness method to decide appropriateness of use of osteoporosis medication after incident fracture and potential for fracture healing and make suggestions for trial design...
4.
Silverman S, Adachi J, Dennison E
Osteoporos Int
. 2015 Dec;
27(3):849-852.
PMID: 26667246
No abstract available.
5.
Silverman S, Wang A, Cheng L, Yang Y, Libanati C, Geller M, et al.
Osteoporos Int
. 2015 Jul;
27(1):75-80.
PMID: 26174879
Unlabelled: Two comorbidity indices were adapted for use in the FREEDOM trial and significantly correlated with the number of medications and impaired health status at baseline. The indices have applications...
6.
Silverman S, Siris E, Kendler D, Belazi D, Brown J, Gold D, et al.
Osteoporos Int
. 2014 Sep;
26(1):361-72.
PMID: 25236877
Unlabelled: To determine persistence with subcutaneous denosumab every 6 months in women being treated for osteoporosis, we conducted a single-arm prospective, observational study in the United States and Canada. Among...
7.
Kanis J, Adachi J, Cooper C, Clark P, Cummings S, Diaz-Curiel M, et al.
Osteoporos Int
. 2013 Jul;
24(11):2763-4.
PMID: 23884436
Unlabelled: The Committee of Scientific Advisors of International Osteoporosis Foundation (IOF) recommends that papers describing the descriptive epidemiology of osteoporosis using bone mineral density (BMD) at the femoral neck include...
8.
Lindsay R, Watts N, Lange J, Delmas P, Silverman S
Osteoporos Int
. 2013 Apr;
24(8):2345-52.
PMID: 23612793
Unlabelled: This observational study showed that after 2 years, both risedronate and alendronate lowered the risk of hip and nonvertebral fractures compared with patients filling in a single bisphosphonate prescription....
9.
Hadji P, Zanchetta J, Russo L, Recknor C, Saag K, McKiernan F, et al.
Osteoporos Int
. 2011 Dec;
23(8):2141-50.
PMID: 22159672
Unlabelled: The effect of teriparatide and risedronate on back pain was tested, and there was no difference in the proportion of patients experiencing a reduction in back pain between groups...
10.
Silverman S, Chines A, Kendler D, Kung A, Teglbjaerg C, Felsenberg D, et al.
Osteoporos Int
. 2011 Jul;
23(1):351-63.
PMID: 21779819
Unlabelled: In this 2-year extension of a 3-year study, bazedoxifene showed sustained efficacy in preventing new vertebral fractures in postmenopausal women with osteoporosis and in preventing non-vertebral fractures in higher-risk...